Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on rare neurological diseases, announced that its management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 10, 2026, with a webcast available to investors.
BranchOut Food Inc. announced initial commercial orders totaling approximately $750,000 for its new front-of-club Crunchy Fruit Chip Multipack Product Line and shelf-stable Dried Cheesecake Bites with the nation’s largest warehouse club retailer. The multipack line is set for launch in Mexico, marking the company's first international warehouse clu…
Catheter Precision, Inc. announced key commercial milestones including its first purchase order through Cardinal Health, an extensive U.S. healthcare distributor, and the first order from Johns Hopkins Hospital for its LockeT suture retention device. Additionally, the company has placed its VIVO 3D Imaging System with a hospital in Germany, marking…
Nasdaq Verafin announced a partnership with Q6 Cyber to integrate dark web fraud intelligence into its financial crime management platform. This alliance aims to provide financial institutions with early alerts on compromised accounts and payment methods, allowing proactive fraud prevention prior to fraudulent transactions. The combined data from Q…
Expion Energy, Inc., a Nasdaq-listed company known for its lithium battery technology, appointed Robert Winspear as Chief Financial Officer, signaling a strategic focus on entering the oil and gas sector alongside its established battery business. Winspear brings extensive capital markets and M&A experience, supporting the company's growth plans an…
Alvotech, a global biotechnology company specializing in biosimilar medicines, announced that its Founder and Chairman, Robert Wessman, and Chief Strategy Officer, Dr. Balaji V. Prasad, will participate in upcoming investor conferences hosted by Morgan Stanley and Deutsche Bank in September 2026. These events include a fireside chat and investor me…
ChronoScale Corporation announced a partnership with Microsoft to deploy a 50-megawatt AI compute infrastructure in North America. The deployment will utilize NVIDIA GB300 NVL72 systems coupled with advanced liquid-cooling technology to support high-density AI workloads. This full-stack infrastructure is designed to meet the power, cooling, network…
Entera Bio Ltd., a clinical stage biotechnology company specializing in oral peptide therapies, announced its CEO Miranda Toledano will participate in several prominent healthcare investor conferences throughout fall 2026. The company highlighted its proprietary N-Tab technology platform and diverse pipeline including its leading osteoporosis candi…
Genius Group Limited announced a $1.2 billion capital plan to fund its dual treasury strategy targeting $800 million in AI assets and $827 million in Bitcoin assets by fiscal year 2031. The company will issue perpetual preferred securities to raise capital without diluting ordinary shareholders, aiming to maximize net asset value per share (NAVPS).…
Apollo Global Management and KKR have partnered strategically with Apollo acquiring a significant interest in Atlantic Aviation, a leading U.S. private aviation infrastructure provider valued at nearly $10 billion. The partnership aims to leverage Atlantic Aviation's extensive airport infrastructure and long-term concessions to capture growth oppor…
Pluri Inc., a biotechnology company operating in the human health and FoodTech sectors, has priced a $3.3 million registered direct offering, including the sale of 2,228,940 common shares to a single healthcare-focused institutional investor at $1.50 per share. Concurrently, the company will issue unregistered warrants exercisable at $1.65 per shar…
Verrica Pharmaceuticals has announced the completion of patient enrollment in the first pivotal Phase 3 trial (COVE-2) evaluating YCANTH® (VP-102) for common warts treatment, with topline data expected in the first quarter of 2027. The company is on track with its global Phase 3 program, which also includes a second trial (COVE-3) over 50% enrolled…
Rank One Computing Corporation (ROC) has won a significant five-year contract valued at $5.1 million to supply its multimodal automated biometric identification system (ABIS) to a major federal national security program. This contract marks a strategic breakthrough for ROC in the U.S. federal biometrics market, establishing a foundational customer …
MBX Biosciences has dosed the first patient in its pivotal Phase 3 oPTimize trial evaluating once-weekly canvuparatide for chronic hypoparathyroidism treatment. Building on positive Phase 2 results, the global trial aims to demonstrate the drug's efficacy and safety as a potential best-in-class parathyroid hormone replacement therapy. This mileston…
Freshpet, a company specializing in refrigerated, fresh pet foods, announced its participation in the Barclays 19th Annual Global Consumer Conference. The event will include a management presentation and webcast outlining their business approach and growth strategy.
Milestone Pharmaceuticals announced data from a longitudinal study showing that paroxysmal supraventricular tachycardia (PSVT) significantly affects patients' daily lives and quality of life even between acute episodes. The study highlights lifestyle changes, activity avoidance, persistent anxiety, and medication side effects as contributors to the…
HealthEquity, Inc. announced robust financial results for the second quarter ended July 31, 2026, including a 10% increase in net income to $65.6 million, an 11% increase in adjusted EBITDA to $167 million, and an 8% rise in revenue to $350.7 million. The company reported record levels in HSA accounts and assets, reflecting strong growth and operat…
Enviri Corporation (NYSE: NVRI), a leading environmental and operational solutions provider in the metal and rail industries, announced its management will participate in the Jefferies Global Industrials Conference and the Lake Street Best Ideas Growth Conference in New York on September 9 and 10, 2026 respectively. The participation underscores En…
CytomX Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug Varsetatug masetecan (Varseta-M) for treating relapsed/refractory metastatic colorectal cancer (R/R mCRC). This designation follows encouraging Phase 1 data and is intended to expedite development and review. CytomX plans to initiate a registra…
Artelo Biosciences, a clinical-stage pharmaceutical company, declared a 1-for-9 reverse stock split of its common stock effective August 31, 2026. This corporate action aims to increase the stock price per share to enhance liquidity and marketability without changing shareholder ownership percentages. All outstanding warrants and derivatives will b…
Red Violet, Inc., a leading identity intelligence and analytics company, announced its participation at Citi's 2026 Global TMT Conference. The company’s CEO and CFO will present and host investor meetings, highlighting its proprietary identity intelligence technologies and AI-powered platform CORE™ used for identity verification, risk mitigation, a…
PodcastOne has acquired exclusive sales and distribution rights to the entertainment podcast ‘Dropping Names… and Other Things with Brent & Jonny,’ hosted by actors Brent Spiner and Jonathan Frakes. This deal expands PodcastOne's portfolio with its 12th new podcast addition this year, broadening its reach in the entertainment podcast sector and enh…
SL Science Holding Limited filed a new Drug Master File with the FDA covering exosomes derived from Gamma Delta T cells. This expands their regulatory documentation beyond just the GDT cells to include the cell-free exosomes, potentially accelerating future development programs. The exosome format may overcome delivery challenges in oncology, notab…
Deutsche Bank analysts, led by Carolin Raab, warn that joining the DAX often fails to deliver sustained share-price outperformance. With STOXX set to review the index on September 3 and changes effective September 21, Lufthansa remains a candidate to rejoin but has seen its prospects dim after Fresenius Medical Care's free-float increase pushed it …
UBS strategists argue that commodity allocations should reach beyond energy into industrial metals, agricultural crops and gold, citing long-term demand drivers and inflation protection. The bank notes ongoing volatility in energy markets, strong El Nino odds for weather-driven crop risks, and central bank activity supporting bullion.
